Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Stinson

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cancer Research|January 7, 2006
Somatic mutations lead to an oncogenic deletion of met in lung cancerMonica Kong-Beltran, Somasekar Seshagiri, Jiping Zha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patientsRobert L Yauch, Thomas Januario, David A Eberhard, et al.
The Journal of Cell Biology|September 10, 2017
Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemiaTrinna L Cuellar, Anna-Maria Herzner, Xiaotian Zhang, et al.
The New England Journal of Medicine|September 4, 2009
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449Charles M Rudin, Christine L Hann, John Laterra, et al.
Communications Biology|August 21, 2019
Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodiesLeonard D Goldstein, Ying-Jiun J Chen, Jia Wu, et al.
Nature Communications|January 20, 2017
A broadly protective therapeutic antibody against influenza B virus with two mechanisms of actionNing Chai, Lee R Swem, Summer Park, et al.
Nature Communications|May 26, 2017
Corrigendum: A broadly protective therapeutic antibody against influenza B virus with two mechanisms of actionNing Chai, Lee R Swem, Summer Park, et al.
Nature Methods|August 21, 2007
Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detectionBrock A Peters, Zhengyan Kan, Dragan Sebisanovic, et al.
Science (New York, N.Y.)|September 4, 2009
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastomaRobert L Yauch, Gerrit J P Dijkgraaf, Bruno Alicke, et al.
Nature Methods|May 23, 2018
CRISPR off-target analysis in genetically engineered rats and miceKeith R Anderson, Maximilian Haeussler, Colin Watanabe, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer Research|January 7, 2006
Somatic mutations lead to an oncogenic deletion of met in lung cancerMonica Kong-Beltran, Somasekar Seshagiri, Jiping Zha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patientsRobert L Yauch, Thomas Januario, David A Eberhard, et al.
The Journal of Cell Biology|September 10, 2017
Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemiaTrinna L Cuellar, Anna-Maria Herzner, Xiaotian Zhang, et al.
The New England Journal of Medicine|September 4, 2009
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449Charles M Rudin, Christine L Hann, John Laterra, et al.
Communications Biology|August 21, 2019
Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodiesLeonard D Goldstein, Ying-Jiun J Chen, Jia Wu, et al.
Nature Communications|January 20, 2017
A broadly protective therapeutic antibody against influenza B virus with two mechanisms of actionNing Chai, Lee R Swem, Summer Park, et al.
Nature Communications|May 26, 2017
Corrigendum: A broadly protective therapeutic antibody against influenza B virus with two mechanisms of actionNing Chai, Lee R Swem, Summer Park, et al.
Nature Methods|August 21, 2007
Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detectionBrock A Peters, Zhengyan Kan, Dragan Sebisanovic, et al.
Science (New York, N.Y.)|September 4, 2009
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastomaRobert L Yauch, Gerrit J P Dijkgraaf, Bruno Alicke, et al.
Nature Methods|May 23, 2018
CRISPR off-target analysis in genetically engineered rats and miceKeith R Anderson, Maximilian Haeussler, Colin Watanabe, et al.
Pageof 4